Founded in 1982 by Dennis Gillings, Ph.D., CBE, and headquartered near Research Triangle Park, North Carolina, we have offices in more than 50 countries and provide services in many more. Our competitive edge lies in our ability to leverage data, therapeutic expertise, full-service capabilities and global resources through an integrated information technology network. We hone our competitive edge by constantly scanning the horizon for opportunities and offering our customers the best information to accelerate and improve healthcare decisions. Corporate Snapshot We help customers succeed by providing services and solutions via three major groups:
QUINTILES® product development services, which provides all clinical research aimed at regulatory approval, and post-launch research and consulting on product safety and value. * Phase I Services for early-phase human drug development.
* Global Clinical Development Services, encompassing all Phase II-IV trial services, such as clinical trial management, medical and regulatory affairs, biostatistics, patient recruitment, ECG services, and drug safety and strategic research.
* Global Central Labs to support all phases of clinical trials. * Global Data Management to capture, analyze and report patient-related data.
* Global Consulting on product development; reimbursement and pricing; health outcomes; regulatory compliance (e.g., FDA enforcement, quality systems); and due diligence for pharmaceutical, biotech and medical device companies.
* Medical Education involving the development and delivery of Continuing Medical Education (CME) programs for health care practitioners.
